Rapid Response Challenge
Funding Rapid Production Launch of Critical Products
In March 2020, NGen launched a challenge program to address urgent needs at the onset of the Covid-19 pandemic. The challenge funded projects that pursued a rapid production launch of products in short supply, including virus screening test kits, gloves, gowns, masks, and other personal protective equipment, hospital equipment such as ventilators and peripherals, as well as cleaning and sterilization chemicals and equipment.
$50 M
NGen Investment
Protecting Canada's Frontline Workers
The rapid response funding supported sixteen Canadian companies and their project partners, representing a total combined investment of over $49 million for the rapid production launch and scale of of critical equipment and supplies. Product categories included a vaccines, test kits, biometric monitoring devices, ventilators and air filtration components, antimicrobial coatings, masks and face shields.
16
Projects
8
Product Categories
Funding Recipients
- ImmunoVaccine Technologies, Dartmouth, NS
- DMF Medical, Dartmouth, NS
- Cloud Diagnostics, Kitchener, ON
- LuminUltra Technologies, Fredericton, NB
- BOMImed, Winnipeg, MB
- Eclipse Automation, Cambridge, ON
- Molded Precision Components (MPC), Oro Medonte, ON
- Response Biomedical, Vancouver, BC
- Sona Nanotech, Halifax, NS
- ExaCad, Boisbrand, QC
- Envision SQ, Guelph, ON
- Myant, Toronto, ON
- Precision Biomonitoring, Guelph, ON
- Mosaic Manufacturing, Toronto, ON
- Burloak, Oakville, ON
- Canadiam Emergency Ventilators Inc. (StarFish Medical), Victoria, BC
Read the full press release here



